The Diabetes Foundation: The application period for next year’s research grants is 15 October to 1 December. Research grants are awarded to applicants at the Medical Faculties of Lund University, Sweden and Geneva University, Switzerland. Read more/apply
Bo Hjelt is the Founder and Honorary Chairman of CDI Global, an industrial search company with offices in 37 countries. Prior to launching CDI Global, he was the Director of European Operations at Svenska Metallverken, a Swedish metals multinational. Bo sits on a number of private and not-for-profit boards. He holds a BA from l’Ecole des Hautes Etudes Commerciales, and an MBA from Centre d’Etudes Industrielles in Geneva.
Professor Claes Wollheim
MD and qualified Swedish physician (Lund University). He is Dr. Honoris Causa, Semmelweis University Budapest and Lund University. Full professor of experimental diabetology, Faculty of Medicine, Geneva (1991-2009). Now, professor emeritus and mentor/consultant, Department of Cell Physiology and Metabolism, University of Geneva and Lund University diabetes Centre. His work has focused on the biology and pathophysiology of the islets of Langerhans, in particular the mechanisms of insulin and glucagon secretion.
MD, PhD. Consultant Orthopaedic Surgeon at Akademiska Sjukhuset, Uppsala, Sweden and private Consultant Orthopaedic Surgeon. Head of the section for Shoulder, Knee and Foot-surgery at the department of Orthopeadic surgery, Akademiska Hospital, Uppsala, Sweden 2004-2006. Ongoing commissions as lecturer in shoulder and knee-surgery at Uppsala University. Member of the Swedish Society of Medicine, the Swedish Medical Association the Swedish Orthopaedic Association and the Swedish Shoulder and Elbow Association.
M.Sc. Engineering, honorary Doctor of Economics. Lund, Sweden.
CEO of the Crafoord Foundation. Chairman of the Erik Philip Sörensen Foundation, the University of Kalmar and Tacticus.
Vice Chairman of Cardo. Director of AFA, AMF Pension and the Albert Pålsson Foundation for Research and Charity, Kalmar Läns Kapitalförvaltning AB and Malmöhus Invest. Former Chairman of Lund University 1997-2003.
CFA, Lombard Odier & Cie, Senior Vice President at Lombard Odier & Cie since 1995.
Chartered Financial Analyst, 1999
Degree in Economics & Finance, University of Geneva, 1994
Dr. Joachim Karsegard
MD. Specialist in Endocrinology and Diabetology since 1997, registrar at Geneva University Hospital, Switzerland, 1994–1998. Installed in liberal medical practice since 1997. Member of the Swiss Society of Internal Medicine, the Swiss Society of Endocrinology and Diabetology, he is the actual President of the Group of Diabetology and Endocrinology of Geneva and vice-president of the Group of Internal and General Medicine of Geneva.
Lena Eliasson is appointed Professor in Experimental Diabetes Research at Lund University and she is part of Lund University Diabetes Centre (LUDC). Her research aims to understand cellular mechanisms underlying impaired islet hormone secretion contributing to the pathogenesis of diabetes. The focus is on single cell physiology involving studies of ion-channels, exocytosis and miRNA networks important in the regulation of islet cell secretion.
For more information see: http://research.med.lu.se/islet-cell-exocytosis
Ph.D. Professor in energy metabolism at the University of Geneva. Pierre Maechler obtained his Master degree in 1986 on neutrophil activation. He then joined a pharma company working on lipid disorders. From studies in this company, he obtained his PhD in 1993 on the mechanisms leading to diabetes-associated hypercholesterolemia. In 1995, he moved back to academia and uncovered the role of glutamate in the control of insulin secretion. Over the years, his research group made seminal contributions for our comprehension of the role of mitochondria in metabolic diseases, in particular diabetes.
Kerstin Hjelt has worked as a physiotherapist for 30 years. She has experience from working with physically and mentally handicapped people and has been closely involved in her husband’s Foundation for research into Spina Bifida.
Claes-Johan Geijer is an independent director, board member and consultant based in Luxembourg. He has a background within management in international industrial corporations and banking most recently as the group head of private baking within the Carnegie Group and managing director of Banque Carnegie Luxembourg. Claes-Johan holds a B.Sc. from the Stockholm School of Economics.
M.D., Ph.D. is since 1993 Professor in Endocrinology at Lund University and Director of Lund University Diabetes Centre. He received his MD at University of Berne, Switzerland and PhD at University of Helsinki, Finland. After a PostDoc period at Yale University he devoted his research to dissection of the heterogeneity of diabetes but also to explore the pathogenic events leading to type 2 diabetes. The research group has been involved in many of the genetic discoveries on type 2 diabetes during the past 15 years, including one of the first whole genome association studies for type 2 diabetes. He has served on numerous editorial boards and achieved several international recognitions, including the Claude Bernard and Anders Jahre awards.